<?xml version='1.0' encoding='utf-8'?>
<document id="12297614"><sentence text="Immunosuppressants." /><sentence text="This edition of the Med-Psych Drug-Drug Interactions Update begins a change in format" /><sentence text=" Starting with this column, each column will feature one drug-drug interaction (DDI) topic that will be explored in depth" /><sentence text=" This edition features DDIs associated with the commonly used immunosuppressants" /><sentence text=" These drugs are frequently encountered by consultation-liaison psychiatrists in tertiary care settings" /><sentence text=" Generally, most of these drugs have narrow safety and therapeutic windows; therefore, other drugs that change their serum levels can have deleterious effects" /><sentence text=" In this review, the DDI profiles of cyclosporine, tacrolimus, sirolimus, and the corticosteroids are explored"><entity charOffset="37-49" id="DDI-PubMed.12297614.s7.e0" text="cyclosporine" /><entity charOffset="51-61" id="DDI-PubMed.12297614.s7.e1" text="tacrolimus" /><entity charOffset="63-72" id="DDI-PubMed.12297614.s7.e2" text="sirolimus" /><entity charOffset="82-97" id="DDI-PubMed.12297614.s7.e3" text="corticosteroids" /><pair ddi="false" e1="DDI-PubMed.12297614.s7.e0" e2="DDI-PubMed.12297614.s7.e0" /><pair ddi="false" e1="DDI-PubMed.12297614.s7.e0" e2="DDI-PubMed.12297614.s7.e1" /><pair ddi="false" e1="DDI-PubMed.12297614.s7.e0" e2="DDI-PubMed.12297614.s7.e2" /><pair ddi="false" e1="DDI-PubMed.12297614.s7.e0" e2="DDI-PubMed.12297614.s7.e3" /><pair ddi="false" e1="DDI-PubMed.12297614.s7.e1" e2="DDI-PubMed.12297614.s7.e1" /><pair ddi="false" e1="DDI-PubMed.12297614.s7.e1" e2="DDI-PubMed.12297614.s7.e2" /><pair ddi="false" e1="DDI-PubMed.12297614.s7.e1" e2="DDI-PubMed.12297614.s7.e3" /><pair ddi="false" e1="DDI-PubMed.12297614.s7.e2" e2="DDI-PubMed.12297614.s7.e2" /><pair ddi="false" e1="DDI-PubMed.12297614.s7.e2" e2="DDI-PubMed.12297614.s7.e3" /></sentence><sentence text="" /></document>